Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Phosphatidylinositol 3-kinase–protein kinase B signaling pathway** (PI3K–Akt pathway) is a crucial intracellular signaling cascade, highly conserved across higher eukaryotes, that plays a central role in cell survival, proliferation, growth, and metabolism. Upon activation by various growth factors, the pathway initiates at the cell membrane via activation of PI3K, which generates lipid second messengers that recruit and activate Akt (also called protein kinase B, PKB). Akt phosphorylates a multitude of substrates, altering various cellular processes including resistance to apoptosis, stimulation of cell cycle progression, and enhancement of cellular growth and metabolism. Dysregulation or hyperactivation of the PI3K–Akt pathway is strongly implicated in oncogenesis, metabolic syndromes, and resistance to targeted therapies.
Inhibition of kinase activity (blocking PI3K or Akt activity directly), blocking upstream receptor activation, reducing downstream signaling for cell survival and growth, and inducing apoptosis in cancer cells by blocking survival signals.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-kinase–protein kinase B signaling pathway (PI3K–Akt signaling pathway).